Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors
ChemMedChem · 2026
DOI: 10.1002/cmdc.70464 ↗At a glance
Journal article in ChemMedChem, 2026. Written by Suyoung Kang and 2 co-authors. Institution: Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic …. Major MEDLINE topics: RNA, Small Interfering, Cholesterol, Nanoparticles, Lipids. 34 references. The full text is freely available in PubMed Central. Funded by: National Research Foundation of Korea.
Abstract (original language)
Lipid nanoparticles (LNPs) are clinically validated platform for the delivery of small interfering RNA (siRNA) therapeutics. However, conventional LNPs typically consist of multiple lipid components, which complicates formulation optimization and limits compositional flexibility. Furthermore, efficient delivery of siRNA to extrahepatic tissues, including solid tumors, remains a major challenge. To address these limitations, we developed a class of ionizable cholesterol derivatives by conjugating biocompatible dimethylated amino acids to cholesterol through a cleavable linker, thereby integrating the structural role of cholesterol and the pH‐responsive ionization of ionizable lipids into a single molecule. Five i‐Chol derivatives were synthesized and formulated into LNPs, which demonstrated efficient siRNA encapsulation and delivery in cancer cells. The resulting siRNA@i‐Chol LNPs exhibited uniform particle size and near‐neutral surface charge, indicating favorable physicochemical properties for systemic administration. Notably, phenylalanine‐based cholesterol LNPs (Phe‐Chol LNPs) loaded with siRNA targeting kinesin spindle protein (KIF11) achieved the most potent in vitro gene knockdown in PC3 prostate cancer cells and induced significant dose‐dependent antitumor activity in a xenograft model without observable systemic toxicity. Collectively, this study establishes a simplified i‐Chol LNP platform that maintains high siRNA delivery efficiency to solid tumors and provides a versatile framework for further LNP engineering and scalable manufacturing.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
- Center for Precision Bio-Nanomedicine, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
ORCID profiles: Suyoung Kang, Duc-Toan Nguyen, Sangyong Jon
Funding
- National Research Foundation of Korea
Cite
APA
Kang, S., Nguyen, D. T., & Jon, S. (2026). Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors. ChemMedChem. https://doi.org/10.1002/cmdc.70464
Vancouver
Kang S, Nguyen DT, Jon S. Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors. ChemMedChem. 2026. doi:10.1002/cmdc.70464
BibTeX
@article{Kang2026,
author = {Kang, Suyoung and Nguyen, Duc-Toan and Jon, Sangyong},
title = {Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70464}
}
EUVIMED